Sign in Register
Posted On: 2 December 2021 11:17 am
Updated On: 2 December 2021 11:36 am

MOPH adds Covaxin to conditionally-approved COVID-19 vaccines

Content Writer
Discuss here!
Start a discussion

The Ministry of Public Health has added Covaxin (developed by Bharat Biotech) to the list of Conditionally Approved COVID-19 Vaccines within its COVID-19 travel and return policy. The approval comes into immediate effect.

Information for those travelling to Qatar with conditionally approved vaccines

The Serology Antibody test with a positive result is mandatory before travelling to Qatar for people with two doses of conditionally approved vaccines and 14 days after the second dose, in which case only the traveller will be considered fully immune.

People who have received two doses of a conditionally approved vaccine followed by one dose of Pfizer or Moderna vaccine and after 14 days from the last dose will be considered fully immune.

Travellers who are fully immunised outside Qatar with a vaccine approved by the Ministry of Public Health of Qatar are required to submit the original vaccine certificate and other supporting documents written in Arabic or English proving that they have obtained the vaccine, as follows:

  • The name of the traveller must be identical to that on the passport.
  • Dose dates by vaccine type (one dose for Jansen vaccine and two doses for other vaccines).
  • Type/name of vaccine.
  • The serial number of the vaccine batch (if any).

Which COVID-19 vaccines are accepted in Qatar?

The following vaccines are approved for travelling to Qatar, as part of its COVID travel and return policy:

Approved vaccines:

  • Pfizer / BioNTech (Comirnaty) - Two Doses
  • Moderna (SpikeVax) - Two Doses
  • AstraZeneca (Covishield / Oxford / Vaxzevria​) - Two Doses
  • Jansen / Johnson & Johnson (only one dose)

*Conditionally approved vaccines:

  • Sinopharm vaccine - Two Doses
  • Sinovac - Two Doses
  • Sputnik V - Two Doses
  • Covaxin - Two Doses (just added to list)

    Source: MOPH